Matches in SemOpenAlex for { <https://semopenalex.org/work/W3183485266> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W3183485266 abstract "Abstract Purpose: Immunomodulatory therapies have shown beneficial effects in patients with severe COVID-19. Patients with hypercytokinemia might benefit from removal of inflammatory mediators via hemadsorption. Methods: Single-center prospective randomized trial at the University Medical Center Hamburg-Eppendorf (Germany). Patients with confirmed COVID-19, refractory shock (norepinephrine ≥0.2 μg/kg/min to maintain a mean arterial pressure ≥ 65 mmHg), IL-6≥500 ng/l and an indication for renal replacement therapy (RRT) or extracorporeal membrane oxygenation (ECMO) were included. Patients received either hemadsorption therapy (HT) or standard medical therapy (SMT). For HT, a CytoSorb® adsorber was used for up to 5 days and was replaced every 18–24 hours. The primary endpoint was sustained hemodynamic improvement (norepinephrine ≤0.05 µg/kg/min≥24h). Secondary endpoints included 28-day mortality, SOFA, and reduction of IL-6, PCT, and MR-proADM. Results: Of 242 screened patients, 24 were randomized and assigned to either HT (N=12) or SMT (N=12). Both groups had similar severity as assessed by SAPS II (median 75 points HT group vs. 79 SMT group, p=0.590) and SOFA (17 vs. 16, p=0.551). At randomization, 22 (92%) patients were on RRT and 11 (46%) had vv-ECMO. Median IL-6 levels were 2269 (IQR 948–3679) and 3747 (1301–5415) ng/l in the HT and SMT group at baseline, respectively (p=0.378). Serum IL-6 reduction in the first 24h of treatment compared between both groups was 83% vs. 46% (p=0.235). Shock resolution (primary endpoint) was reached in 33% (4/12) vs. 17% (2/12) in the HT and SMT group, respectively (p=0.640). 28-day mortality was 58% (7/12) in the HT compared to 67% (8/12) in the SMT group (p=1.0). Conclusion: HT was associated with a non-significant trend towards clinical improvement within the intervention period including reduction of IL-6 levels and shock resolution. In selected patients, HT might therefore be an option for stabilization and bridge to transfer and decision. ( Trial registration: ClinicalTrials.gov: NCT04344080, https://clinicaltrials.gov/ct2/show/NCT04344080, trial registration date 04/14/2020)]" @default.
- W3183485266 created "2021-08-02" @default.
- W3183485266 creator A5029567930 @default.
- W3183485266 creator A5035194118 @default.
- W3183485266 creator A5038348127 @default.
- W3183485266 creator A5043074143 @default.
- W3183485266 creator A5055078434 @default.
- W3183485266 creator A5057618004 @default.
- W3183485266 creator A5057806319 @default.
- W3183485266 creator A5073246444 @default.
- W3183485266 creator A5076823010 @default.
- W3183485266 creator A5079018056 @default.
- W3183485266 creator A5085547907 @default.
- W3183485266 date "2021-07-23" @default.
- W3183485266 modified "2023-09-27" @default.
- W3183485266 title "Effect of Hemadsorption in Critically Ill Patients with COVID-19 (CYTOCOV-19): A Prospective Randomized Controlled Pilot Trial" @default.
- W3183485266 doi "https://doi.org/10.21203/rs.3.rs-704552/v1" @default.
- W3183485266 hasPublicationYear "2021" @default.
- W3183485266 type Work @default.
- W3183485266 sameAs 3183485266 @default.
- W3183485266 citedByCount "1" @default.
- W3183485266 countsByYear W31834852662023 @default.
- W3183485266 crossrefType "posted-content" @default.
- W3183485266 hasAuthorship W3183485266A5029567930 @default.
- W3183485266 hasAuthorship W3183485266A5035194118 @default.
- W3183485266 hasAuthorship W3183485266A5038348127 @default.
- W3183485266 hasAuthorship W3183485266A5043074143 @default.
- W3183485266 hasAuthorship W3183485266A5055078434 @default.
- W3183485266 hasAuthorship W3183485266A5057618004 @default.
- W3183485266 hasAuthorship W3183485266A5057806319 @default.
- W3183485266 hasAuthorship W3183485266A5073246444 @default.
- W3183485266 hasAuthorship W3183485266A5076823010 @default.
- W3183485266 hasAuthorship W3183485266A5079018056 @default.
- W3183485266 hasAuthorship W3183485266A5085547907 @default.
- W3183485266 hasBestOaLocation W31834852661 @default.
- W3183485266 hasConcept C121332964 @default.
- W3183485266 hasConcept C126322002 @default.
- W3183485266 hasConcept C141071460 @default.
- W3183485266 hasConcept C142424586 @default.
- W3183485266 hasConcept C168563851 @default.
- W3183485266 hasConcept C188816634 @default.
- W3183485266 hasConcept C203092338 @default.
- W3183485266 hasConcept C204243189 @default.
- W3183485266 hasConcept C2776858399 @default.
- W3183485266 hasConcept C2777465075 @default.
- W3183485266 hasConcept C2779541074 @default.
- W3183485266 hasConcept C2779915274 @default.
- W3183485266 hasConcept C2991859549 @default.
- W3183485266 hasConcept C42219234 @default.
- W3183485266 hasConcept C71924100 @default.
- W3183485266 hasConcept C87355193 @default.
- W3183485266 hasConceptScore W3183485266C121332964 @default.
- W3183485266 hasConceptScore W3183485266C126322002 @default.
- W3183485266 hasConceptScore W3183485266C141071460 @default.
- W3183485266 hasConceptScore W3183485266C142424586 @default.
- W3183485266 hasConceptScore W3183485266C168563851 @default.
- W3183485266 hasConceptScore W3183485266C188816634 @default.
- W3183485266 hasConceptScore W3183485266C203092338 @default.
- W3183485266 hasConceptScore W3183485266C204243189 @default.
- W3183485266 hasConceptScore W3183485266C2776858399 @default.
- W3183485266 hasConceptScore W3183485266C2777465075 @default.
- W3183485266 hasConceptScore W3183485266C2779541074 @default.
- W3183485266 hasConceptScore W3183485266C2779915274 @default.
- W3183485266 hasConceptScore W3183485266C2991859549 @default.
- W3183485266 hasConceptScore W3183485266C42219234 @default.
- W3183485266 hasConceptScore W3183485266C71924100 @default.
- W3183485266 hasConceptScore W3183485266C87355193 @default.
- W3183485266 hasLocation W31834852661 @default.
- W3183485266 hasOpenAccess W3183485266 @default.
- W3183485266 hasPrimaryLocation W31834852661 @default.
- W3183485266 hasRelatedWork W1993761433 @default.
- W3183485266 hasRelatedWork W2107690372 @default.
- W3183485266 hasRelatedWork W2589015111 @default.
- W3183485266 hasRelatedWork W2796126755 @default.
- W3183485266 hasRelatedWork W2810895440 @default.
- W3183485266 hasRelatedWork W2887348953 @default.
- W3183485266 hasRelatedWork W3110819205 @default.
- W3183485266 hasRelatedWork W3137657866 @default.
- W3183485266 hasRelatedWork W4308304671 @default.
- W3183485266 hasRelatedWork W1777239160 @default.
- W3183485266 isParatext "false" @default.
- W3183485266 isRetracted "false" @default.
- W3183485266 magId "3183485266" @default.
- W3183485266 workType "article" @default.